Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × resminostat × Clear all

NCT02400788 2018-01-16

Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular